FDA Import Refusal NUV-3887395-9/10002/1 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA refused shipment NUV-3887395-9/10002/1 from Novo Nordisk A/S (Denmark) on April 16, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.